Evidence map›Paper›PMID 27316687›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Stromelysin-2 (MMP10) Moderates Inflammation by Controlling Macrophage Activation.

Ryan S McMahan, Timothy P Birkland, Kate S Smigiel, Tyler C Vandivort, Maryam G Rohani, Anne M Manicone, John K McGuire, Sina A Gharib, William C Parks

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 96 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ryan S McMahanCenter for Lung Biology, University of Washington, Seattle, WA 98109; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98105;ORCID 0000-0003-3489-6127
Timothy P BirklandCenter for Lung Biology, University of Washington, Seattle, WA 98109; Department of Medicine, University of Washington, Seattle, WA 98195;
Kate S SmigielWomen's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048; and.
Tyler C VandivortCenter for Lung Biology, University of Washington, Seattle, WA 98109; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98105; Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048; and.ORCID 0000-0003-0475-2923
Maryam G RohaniCenter for Lung Biology, University of Washington, Seattle, WA 98109; Department of Medicine, University of Washington, Seattle, WA 98195; Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048; and.
Anne M ManiconeCenter for Lung Biology, University of Washington, Seattle, WA 98109; Department of Medicine, University of Washington, Seattle, WA 98195;
John K McGuireCenter for Lung Biology, University of Washington, Seattle, WA 98109; Department of Pediatrics, University of Washington, Seattle, WA 98195.ORCID 0000-0001-6106-8349
Sina A GharibCenter for Lung Biology, University of Washington, Seattle, WA 98109; Department of Medicine, University of Washington, Seattle, WA 98195;
William C ParksCenter for Lung Biology, University of Washington, Seattle, WA 98109; Department of Medicine, University of Washington, Seattle, WA 98195; Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048; and bill.parks@cshs.org.
University of Washington · USCedars-Sinai Medical Center · US

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI ALI SHOJAIE · 1995 to 2026
$42.5M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Thymic Stromal Lymphopoietin (TSLP) and Lung Inflammation and ImmP01HL098067 · NHLBI · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI FREVERT, CHARLES WAYNE · 2010 to 2014
$13.5M
MMP28 Regulation Of Macrophage Recruitment and PolarizationR01HL116514 · NHLBI · UNIVERSITY OF WASHINGTON · PI MANICONE, ANNE M. · 2014 to 2018
$2.2M
E-cadherin shedding in chronic lung injuryR01HL093022 · NHLBI · UNIVERSITY OF WASHINGTON · PI MCGUIRE, JOHN K · 2010 to 2014
$2.0M
MMP10 Control of Macrophage Activation in COPDR01HL089455 · NHLBI · UNIVERSITY OF WASHINGTON · PI PARKS, WILLIAM C · 2011 to 2014
$1.7M
Role of MMP10 in Macrophage ActivationR56HL128995 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI PARKS, WILLIAM C · 2015 to 2015
$540k
NHLBI NIH HHS P01 HL098067NHLBI NIH HHS R01 HL089455NHLBI NIH HHS R01 HL093022NHLBI NIH HHS R01 HL116514NHLBI NIH HHS R56 HL128995NIDDK NIH HHS P30 DK017047NIEHS NIH HHS P30 ES007033
6 · The paper itself

Abstract

Several members of the matrix metalloproteinase (MMP) family control a range of immune processes, such as leukocyte influx and chemokine activity. Stromelysin-2 (MMP10) is expressed by macrophages in numerous tissues after injury; however, little is known of its function. In this study, we report that MMP10 is expressed by macrophages in human lungs from patients with cystic fibrosis and induced in mouse macrophages in response to Pseudomonas aeruginosa infection both in vivo and by isolated resident alveolar and bone marrow-derived macrophages (BMDM). Our data indicates that macrophage MMP10 serves a beneficial function in response to acute infection. Whereas wild-type mice survived infection with minimal morbidity, 50% of Mmp10(-/-) mice died and all showed sustained weight loss (morbidity). Although bacterial clearance and neutrophil influx did not differ between genotypes, macrophage numbers were ∼3-fold greater in infected Mmp10(-/-) lungs than in wild-types. Adoptive transfer of wild-type BMDM normalized infection-induced morbidity in Mmp10(-/-) recipients to wild-type levels, demonstrating that the protective effect of MMP10 was due to its production by macrophages. Both in vivo and in cultured alveolar macrophages and BMDM, expression of several M1 macrophage markers was elevated, whereas M2 markers were reduced in Mmp10(-/-) tissue and cells. Global gene expression analysis revealed that infection-mediated transcriptional changes persisted in Mmp10(-/-) BMDM long after they were downregulated in wild-type cells. These results indicate that MMP10 serves a beneficial role in response to acute infection by moderating the proinflammatory response of resident and infiltrating macrophages.

Indexed as

Adoptive TransferAnimalsCystic FibrosisFemaleFlow CytometryHumansImmunohistochemistryInflammationIn Situ HybridizationMacrophage ActivationMacrophagesMaleMatrix Metalloproteinase 10MiceMice, Inbred C57BLMice, KnockoutMatrix Metalloproteinase 10

Identifiers

PMID27316687
PMCPMC4955757
OpenAlexW2436504951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.